Clinisys Joins the Royal College of Pathologists as a Corporate Member
We are delighted to announce that Clinisys is now a Corporate Member of the Royal College of Pathologists (RCPath), marking an important milestone in our ongoing commitment to supporting pathology…
Read the full articleYou might also wanna read
Pharmaceutical companies commit to new principles on using NHS data for research
Pharmaceutical companies today committed to following a new set of principles for use of NHS data which pledge the highest levels of transpa
Gilead Sciences joins the ABPI
Gilead Sciences has joined the membership of the Association of the British Pharmaceutical Industry, effective from January 2022.
Sue Griffin: Happy to Join the Centre for Drug Development as CSO
Sue Griffin, CSO at the Centre for Drug Development, shared a post on LinkedIn by Lars Erwig, Director Centre of Drug Development Cancer Res
GlaxoSmithKline submits European marketing authorisation application for Pazopanib in advanced kidney cancer
GSK announced submission of MAA to EMEA for pazopanib, oral therapy for metastatic renal cell carcinoma (RCC).
Celltrion Poised for Profitability Leap on New Biosimilars
Celltrion is poised for a profitability leap as new biosimilars like Remsima SC and Omlyclo boost its product mix, with Q2 operating profit
Health and social care leaders unite to improve public involvement in research
Funders, regulators and research organisations sign up to a bold new shared commitment to improve public involvement in research.
Comments
Sign in to join the conversation.
No comments yet. Be the first.